Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

1446089-83-3Capecitabine Methoxy Analog

● In Stock

Catalogue No.:	VE007565
CAS No.:	1446089-83-3
Mol. Formula:	C11H14FN3O6
Mol. Weight:	303.24 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 1446089-83-3

Parent drug

Capecitabine

IUPAC Name

(1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-1, 2-dihydro-2-oxo-4-pyrimidinyl)-carbamic acid methyl ester

Pharmacopoeial Synonyms

N/A

Other Synonyms

Capecitabine Impurity M;Cinnamyldenafil;5-(2-Ethoxy-5-(2-(4-(3-phenyl-2-propen-1-yl)-1-piperazinyl)acetyl)phenyl)-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo(4,3-d)pyrimidin-7-one;7H-Pyrazolo(4,3-d)pyrimidin-7-one, 5-(2-ethoxy-5-(2-(4-(3-phenyl-2-propen-1-yl)-1-piperazinyl)acetyl)phenyl)-1,6-dihydro-1-methyl-3-propyl

Smile

O=C(OC)NC(C(F)=CN1[C@H]2[C@@H]([C@@H]([C@@H](C)O2)O)O)=NC1=O

Inchl

InChI=1S/C11H14FN3O6/c1-4-6(16)7(17)9(21-4)15-3-5(12)8(13-10(15)18)14-11(19)20-2/h3-4,6-7,9,16-17H,1-2H3,(H,13,14,18,19)/t4-,6-,7-,9-/m1/s1

Description

The compound Capecitabine Methoxy Analog is a highly characterized reference material that meets stringent regulatory standards, including those set by USP, EMA, JP, and BP. This product is essential for a variety of applications, such as analytical method development, method validation (AMV), and Quality Control (QC), particularly in the context of Capecitabine production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). Additionally, the product comes with a detailed Structure Elucidation Report (SER), ensuring its precision and reliability for comprehensive analytical use.